AZ will open compound library to malaria researchers

The non-profit Medicines for Malaria Venture has just landed another Big Pharma backer. AstraZeneca says that it will open up the books on some 500,000 chemical compounds to help researchers track down new therapies to treat malaria--including some hard-to-treat strains of the disease. "Our experience with infection research, and indeed with all of our R&D efforts, has taught us that we will only find solutions to today's global health challenges through collaborative efforts,"...